|
| 35289472 | Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry. | Cytometry Part B - Clinical Cytometry | 2023 |
| 36221810 | Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers. | European Journal of Heart Failure | 2023 |
| 36219593 | Clonal hematopoiesis in patients with stem cell mobilization failure: a nested case-control study. | Blood advances | 2023 |
| 36322930 | Germ line DDX41 mutations define a unique subtype of myeloid neoplasms. | Blood | 2023 |
| 37846136 | Evolution of clonal hematopoiesis. | | 2023 |
| 37844518 | The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A. | | 2023 |
| 37595034 | regulates one-carbon metabolism and histone methylation in ground-state pluripotency. | | 2023 |
| 37914482 | 10-day decitabine versus 3â¿¿+â¿¿7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial. | Lancet Haematol | 2023 |
| 37728691 | Human CD34-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8 T cell and NK cell responses in vitro and in vivo. | | 2023 |
| 37720253 | Clonal Hematopoiesis Defined by Somatic Mutations Infrequently Co-occurs With Mosaic Loss of the Y Chromosome in a Population-based Cohort. | | 2023 |
| 37632778 | Clonal hematopoiesis and UBA1 mutations in individuals with biopsy-proven giant cell arteritis and population-based controls. | | 2023 |
| 37477653 | Good manufacturing practice production of CD34<sup>+</sup> progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia. | Cancer Immunol Immunother | 2023 |
| 37092027 | Effect of Eculizumab on Iron Metabolism in Transfusion-independent Patients With Paroxysmal Nocturnal Hemoglobinuria. | | 2023 |
| 36713353 | Sex Differences in the Spectrum of Clonal Hematopoiesis. | | 2023 |
| 37146604 | Evolutionary landscape of clonal hematopoiesis in 3,359 individuals from the general population. | Cancer Cell | 2023 |
| 36698617 | Abnormal Platelet Counts and Clonal Hematopoiesis in the General Population. | | 2023 |
| 36807648 | High expression of an intragenic long noncoding RNA misinterpreted as high FTO oncogene expression in NPM1 mutant acute myeloid leukemia. | | 2023 |
| 36865907 | In patients with hemophilia, a decreased thrombin generation profile is associated with a severe bleeding phenotype. | | 2023 |
| 36792658 | Immunophenotypic aberrant hematopoietic stem cells in myelodysplastic syndromes: a biomarker for leukemic progression. | | 2023 |
| 34638130 | The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11. | Blood Adv | 2022 |
| 35697783 | Integrated multi-omics reveal polycomb repressive complex 2 restricts human trophoblast induction. | Nat Cell Biol | 2022 |
| 35561316 | Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals. | Blood Adv | 2022 |
| 35732831 | The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. | Leukemia | 2022 |
| 35984907 | Dietary methionine starvation impairs acute myeloid leukemia progression. | Blood | 2022 |
| 34316017 | Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results. | Leukemia | 2022 |
| 35024892 | Genetic diversity within leukemia-associated immunophenotype-defined subclones in AML. | Annals of Hematology | 2022 |
| 34768283 | TET2 mutations as a part of DNA dioxygenase deficiency in myelodysplastic syndromes. | Blood Adv | 2022 |
| 34450246 | Characterization of a genomic region 8Â kb downstream of GFI1B associated with myeloproliferative neoplasms. | | 2021 |
| 33690840 | Specific proteome changes in platelets from individuals with GATA1-, GFI1B-, and RUNX1-linked bleeding disorders. | Blood | 2021 |
| 33796917 | Clinically applicable CD34-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses. | Cancer Immunology, Immunotherapy | 2021 |
| 33877299 | Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged â¿¥80 years. | Blood advances | 2021 |
| 33824442 | Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation. | Bone Marrow Transplantation | 2021 |
| 33765355 | Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)-mutant myelodysplastic syndromes subtype. | British Journal of Haematology | 2021 |
| 33359455 | Multicenter Next-Generation Sequencing Studies between Theory and Practice: Harmonization of Data Analysis Using Real-World Myelodysplastic Syndrome Data. | J Mol Diagn | 2021 |
| 33140189 | IL-15 superagonist N-803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34⿿progenitor-derived NK cells. | Cancer Immunology, Immunotherapy | 2021 |
| 34524494 | Correction to: IL⿿15 superagonist N⿿803 improves IFNγ production and killing of leukemia and ovarian cancer cells by CD34+ progenitor⿿derived NK cells. | Cancer Immunology, Immunotherapy | 2021 |
| 34459888 | Peripheral blood cytopenias in the aging general population and risk of incident hematological disease and mortality. | Blood Adv | 2021 |
| 34616589 | CD34 progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rg mice. | OncoImmunology | 2021 |
| 33054062 | Transcription factor 4 () expression predicts clinical outcome in mutated and translocated acute myeloid leukemia. | Haematologica | 2020 |
| 32268953 | Harnessing natural killer cells for the treatment of ovarian cancer. | Gynecologic Oncology | 2020 |
| 32367046 | In vitro capture and characterization of embryonic rosette-stage pluripotency between naive and primed states. | Nat Cell Biol | 2020 |
| 32243522 | Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals. | Blood | 2020 |
| 32124467 | Platelet CD34 expression in a patient with a partial deletion of transcription factor subunit CBFB. | American Journal of Hematology | 2020 |
| 32347921 | SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS. | Blood | 2020 |
| 31826241 | Impact of NPM1/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia. | Blood | 2020 |
| 33585229 | The Effect of Mutation on the DNA Damage Response and Nonsense-Mediated mRNA Decay in Cancer. | Frontiers in Oncology | 2020 |
| 33049054 | Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial. | Blood Adv | 2020 |
| 33205068 | Malignant Transformation Involving <i>CXXC4</i> Mutations Identified in a Leukemic Progression Model of Severe Congenital Neutropenia. | Cell Rep Med | 2020 |
| 32528120 | PD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity. | Bone Marrow Transplantation | 2020 |
| 32747829 | Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes. | Nat Med | 2020 |